Thomas J. Riga - 03 Jan 2023 Form 4 Insider Report for SPECTRUM PHARMACEUTICALS INC

Role: CEO & President, Director
Signature: /s/ Keith M. McGahan, Attorney-in-Fact for Thomas J. Riga
Issuer symbol: N/A
Transactions as of: 03 Jan 2023
Net transactions value: -$9,141
Form type: 4
Filing time: 05 Jan 2023, 18:50:21 UTC
Previous filing: 13 Feb 2023
Next filing: 01 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SPPI	Common Stock, $0.001 par value	Sale	$9,141	-23,929	-2%	$0.3820	1,189,411	03 Jan 2023	Direct	F1
transaction	SPPI	Common Stock, $0.001 par value	Award	$0	+888,000	+75%	$0.000000	2,077,411	03 Jan 2023	Direct	F2
holding	SPPI	Common Stock, $0.001 par value						14,139	03 Jan 2023	By 401(k) plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SPPI	Stock Option (Right to Buy)	Award	$0	+3,112,000		$0.000000	3,112,000	03 Jan 2023	Common Stock	3,112,000	$0.3800	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
F2	One third of the aggregate amount of restricted stock units shall vest on each of January 3, 2024, 2025 and 2026, respectively.
F3	One third of the aggregate amount of option shares shall vest on each of January 3, 2024, 2025 and 2026, respectively.